Shenzhen YHLO Biotech (688575.SS) Earnings Analysis

Shenzhen YHLO Biotech (688575.SS) next reports earnings on 2026-08-27. Trailing P/E 128.71.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 688575.SS next report earnings?

Next earnings date2026-08-27
Consensus EPS estimaten/a
Revenue estimate0.41B

688575.SS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-290.0314 CNYn/an/an/a
2026-02-27-0.0483 CNYn/an/an/a
2025-10-300.05987 CNYn/an/an/a
2025-04-250.02 CNYn/an/an/a
2025-02-270.154 CNYn/an/an/a
2024-08-290.1879 CNYn/an/an/a

688575.SS valuation and analyst view

Trailing P/E128.71
Trailing EPS0.05569 CNY
Price / book1.90
Dividend yield0.23%
Market cap5.15B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Shenzhen YHLO Biotech (688575.SS)'s next earnings date?

Shenzhen YHLO Biotech is next scheduled to report on 2026-08-27 and revenue estimate of 0.41B.

Did 688575.SS beat earnings last quarter?

Consensus estimate data was not available for 688575.SS's 2026-04-29 report.

What is 688575.SS's current P/E ratio and EPS?

688575.SS trades at a trailing P/E of 128.71 on trailing EPS of 0.05569185438343767 CNY.

What do analysts rate 688575.SS?

688575.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.